These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Current aspects of drug correction of impaired circulation in the ocular vessels]. Kiseleva TN; Polunin GS; Lagutina IuM Vestn Oftalmol; 2007; 123(2):37-9. PubMed ID: 17650609 [No Abstract] [Full Text] [Related]
3. Effect of pyridinolcarbamate (PDC) on surface microvessels in man: preliminary findings. Rouen LR; Terry EN; Clauss RH; Redisch W Bibl Anat; 1975; 13():358-9. PubMed ID: 1231780 [No Abstract] [Full Text] [Related]
4. [The effect of pyridinolcarbamate on the skin microcirculation in patients with severe skin necroses. A double-blind trial study]. Fagrell B Vasa; 1976; 5(4):366-72. PubMed ID: 1007546 [No Abstract] [Full Text] [Related]
5. [Experimental studies of parmidin (pyridinolcarbamate) effect on microvascular permeability of the lungs, skin and mesentery]. Gorizontoba MP; Shvarts GIa Biull Eksp Biol Med; 1979 Sep; 88(9):272-5. PubMed ID: 519015 [TBL] [Abstract][Full Text] [Related]
6. Somatostatin-related therapeutics in ophthalmology: a review. Missotten T; Baarsma GS; Kuijpers RW; van den Born LI; van der Loos T; Croxen R; Hofland LJ; van Hagen PM J Endocrinol Invest; 2005; 28(11 Suppl International):118-26. PubMed ID: 16625860 [TBL] [Abstract][Full Text] [Related]
7. [New therapeutical perspectives in ophthalmology]. Riu R; Darleguy P; Gacon R Therapeutique; 1970 Nov; 46(9):925-8. PubMed ID: 5486143 [No Abstract] [Full Text] [Related]
8. [Clinical experiences with pyridinolcarbamate in ophthalmology]. Musini A; Fabbri G; Tancini G Ann Ottalmol Clin Ocul; 1969 Feb; 95(2):101-23. PubMed ID: 5398786 [No Abstract] [Full Text] [Related]
9. [Preliminary study of a work concerning the activity of pyridinol carbamate on diabetic angiopathy (study of the microcirculation)]. Le Devehat C; Lemoine A Journ Annu Diabetol Hotel Dieu; 1977; ():389-93. PubMed ID: 894879 [No Abstract] [Full Text] [Related]
12. The effect of pyridinolcarbamate after acute and chronic administration in patients with atherosclerosis obliterans. Roztocil K; Oliva J; Linhart J; Prerovský I; Modr Z Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):135-8. PubMed ID: 844932 [TBL] [Abstract][Full Text] [Related]
13. Symposium on drugs used in eye diseases. American Academy of Ophthalmology. Ophthalmology; 1979 Jan; 86(1):79-169. PubMed ID: 530568 [No Abstract] [Full Text] [Related]
15. [Contribution of angioxine to the vascular protection of the diabetic]. Journ Annu Diabetol Hotel Dieu; 1976 May; ():319-27. PubMed ID: 796526 [No Abstract] [Full Text] [Related]
17. [Microcirculation problem and eye pathology]. Kashintseva LT Oftalmol Zh; 1982; 37(8):453-7. PubMed ID: 7162735 [No Abstract] [Full Text] [Related]
18. [Applications of botulinum toxin in ophthalmology]. Lanzl I; Merté RL; Roggenkämper P Klin Monbl Augenheilkd; 2009 Jan; 226(1):R1-8; quiz R9-12. PubMed ID: 19173157 [No Abstract] [Full Text] [Related]
19. The British Journal of Ophthalmology. At a glance. Dua HS; Singh AD Br J Ophthalmol; 2008 Jul; 92(7):869. PubMed ID: 18577632 [No Abstract] [Full Text] [Related]
20. [Lymphological methods of treatment in ophthalmology]. Subbotina IN Vestn Oftalmol; 1999; 115(1):36-7. PubMed ID: 10207322 [No Abstract] [Full Text] [Related] [Next] [New Search]